PSC
BSX icon

Prentiss Smith & Co’s Boston Scientific BSX Stock Holding History

Prentiss Smith & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-5,000
Closed -$46K – 250
2013
Q2 		$46K Buy
+5,000
New +$42.4K 0.02% 123

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Prentiss Smith & Co's BSX Position: Q3 2013 in Review

Prentiss Smith & Co sold out of Boston Scientific (BSX) in Q3 2013, closing a stake of 5,000 shares — an estimated $46K sold.

Prentiss Smith & Co first reported a position in BSX in Q2 2013 and held it in 1 quarter. The position peaked at $46K in Q2 2013. 418 funds tracked by Wall St. Rank hold BSX as of Q3 2013.

  • Prentiss Smith & Co reported no remaining Boston Scientific position as of Q3 2013 after selling out during the quarter.
  • Prentiss Smith & Co sold 5,000 Boston Scientific shares in Q3 2013, an estimated $46K.
  • Prentiss Smith & Co first reported a position in Boston Scientific in Q2 2013 and held it in 1 quarter.
  • Prentiss Smith & Co's Boston Scientific position peaked at $46K in Q2 2013.
  • 418 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2013.

Based on Prentiss Smith & Co's 13F filing for Q3 2013, filed 1 Nov 2013.